| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H38N2O4 |
| Molecular Weight | 526.6658 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(C)=C(NC(=O)C[C@H](CC(O)=O)C2=C3C=CC=CC3=CC=C2)C(=C1)C(=O)N4CCC5(CCCC5)CC4
InChI
InChIKey=MFOOVZCXWVAWOV-RUZDIDTESA-N
InChI=1S/C33H38N2O4/c1-22-18-23(2)31(28(19-22)32(39)35-16-14-33(15-17-35)12-5-6-13-33)34-29(36)20-25(21-30(37)38)27-11-7-9-24-8-3-4-10-26(24)27/h3-4,7-11,18-19,25H,5-6,12-17,20-21H2,1-2H3,(H,34,36)(H,37,38)/t25-/m1/s1
| Molecular Formula | C33H38N2O4 |
| Molecular Weight | 526.6658 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 2.3 nM [IC50] |
